International Spirits & Beverage Group, Inc. (OTCQB: ISBG): Low Price Cannabis Stock Investment Opportunity
January 25 2019 - 8:39AM
InvestorsHub NewsWire
International Spirits & Beverage Group,
Inc. (OTCQB:
ISBG): Low Price Cannabis Stock Investment
Opportunity
Palm
Beach, FL -- January 25, 2019 -- InvestorsHub NewsWire -- (Hotmjstocks.com NEWMJPLAY) — Hotmjstocks.com, a
leading independent small cap media portal with an extensive
history of providing unparalleled content for the growing cannabis
market, reports on
International Spirits & Beverage Group, Inc. (OTCQB: ISBG).
One
of the fastest growing investment areas globally is the cannabis
industry. New investment opportunities are being led by companies
such as ISBG, International Spirits & Beverage Group,
Inc. ISBG has a successful investment portfolio of spirits
and is diversifying into products such as CBD oil, CBD edible
products – in particular the CBD Gummies. ISBG has been gearing itself up to launch a series of
CBD products in January 2019 with targeted plans to reach a
significant market share.
Cannabidiol, commonly known as CBD, has been
scientifically proven to be the marijuana compound that provides
health benefits backed up by an increasing number of governments
and local administrations putting in place structures for
manufacture and trading with successful results. The growth in the
cannabis industry has been phenomenal. Demand for CBD life products
related to health benefits is rising which provides some exciting
opportunities for investors in MJ
stocks.
ISBG is keen to embrace support not only with the
industry but also within the cannabis community nationally and
internationally. Investments are available as penny stocks that
provide minimal investment risks with the promise of healthy
dividends should prices rise as predicted.
The
cannabis industry is expected to double in size to $21bn by 2021 in
the US alone. Globally markets are opening for a growing range of
CBD products with other companies entering the cannabis industry
including long established pharmaceutical manufacturers recognising
the market opportunities. The advantage of ISBG cannabis products
are the potential for high prices and generous
dividends.
Their
product range is soon to include CBD infused drinks. As a company
established in the drinks industry ISBG is well placed to
understand market developments and hence made plans for increasing
their range of products. Slow moves by already established
large players to enter this market has led to ISGB’s plans and
goals to be market leaders of CBD infused drinks , and their
aspiration to be a dominant leader may not be
fanciful.
Competition in the cannabis industry has been
restricted because of licensing requirements making entry into
markets a lot more difficult for new companies. There is a
lot of interest, in particular from potential micro businesses who
may be able to attract local demand but government transportation
rules restrict the opportunities for growth. ISBG has the advantage over a number of competitors to
have flexible approaches to decision making and ahead of the game
in research, development and product launch
plans.
Some
large companies diversifying into the cannabis industry are
restricted by cumbersome decision making processes and risk averse
which is demonstrated by small commitments to entering this
market. Added to which, prices changes to stocks can be
attributed to a range of factors. An established brand in the
drinks sector diversification into CBD products is a natural
complement to the spirits and wines already available, especially
CBD edible products.
It
will be interesting to see how ISBG progress. The indications are full of promise
because of an already established reputation and a sensible
strategic vision that has been well informed. Time will tell as to
how ISBG stocks perform but at the current
competitive prices the likelihood of good returns for investors is
healthy.
In Other News
Canadian pot producer Tilray (TLRY) on Tuesday said it would acquire cannabis
cultivator Natura Naturals Holdings. Tilray stock and other
marijuana stocks were mixed, though Cronos Group(CRON) cleared a buy point intraday.
Tilray said the deal will likely
close in the next 30 days. Once the deal closes, Tilray will pay 35
million Canadian dollars ($26.2 million) — 15 million in cash and
20 million in Tilray stock.
Tilray also said it could also pay Natura up to
35 million Canadian dollars more in stock if Natura hits certain
production targets. That would bring the total purchase price of
the deal to 70 million Canadian dollars.
As
marijuana shortages strain Canada's recreational market, Cowen
analysts noted the deal would roughly double Tilray's production
capacity. Cowen also provided a "fairness opinion" to Tilray's
board in connection with the deal.
The
acquisition would give Tilray a 662,000 square-foot greenhouse
cultivation facility run by Natura. Tilray said 155,000 square
feet in that facility are currently
licensed.
"Through an extensive and thorough search for
the right supply partner, we're pleased to have come to a
mutually-beneficial agreement with Natura," Tilray CEO Brendan
Kennedy said in a statement.
About
Hotmjstocks.com
Hotmjstocks.com is not a registered
investment advisor or a broker-dealer. Investors should not rely on
information given by Hotmjstocks.com to make investment decisions;
rather, investors should use the information as a starting point to
do additional independent research so that they are able to make
their own investment decision. Any materials provided by
Hotmjstocks.com should never be construed as an offer or
solicitation to buy, sell, or hold securities. The information
contained in our reports should be viewed as commercial
advertisement and is not intended to be investment
advice.
Contact
Hotmjstocks.com
Jason
Lopez
Hotmjstocks@gmail.com